Could a simple swab replace a lung scope for pneumocystis diagnosis?
NCT ID NCT06890078
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a mouthwash or a nasal swab can accurately detect pneumocystis pneumonia (PcP) in immunocompromised patients. Currently, diagnosis often requires a bronchoscopy, which is invasive and uncomfortable. Researchers will compare the new non-invasive methods with standard tests in 240 adults with suspected PcP. If the simpler methods work well, they could make diagnosis faster and easier for patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simpler, less invasive way to diagnose pneumocystis pneumonia, reducing the need for uncomfortable bronchoscopies.
- What could go wrong
- This is an early diagnostic study, not a treatment trial. The new methods may not be accurate enough to replace current tests, and results may not apply to all patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOCOMPROMISED PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Lariboisière AP-HP Maladies infectieuses
RECRUITINGParis, France
-
Hôpital Saint Louis AP-HP Maladies infectieuses
RECRUITINGParis, France
-
Hôpital Saint Louis AP-HP Réanimation
RECRUITINGParis, France
-
Hôpital Saint-Louis AP-HP Pneumologie
RECRUITINGParis, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood markers may forecast survival in intensive care patients
- New score could help doctors spot fungal pneumonia faster
- Antibody therapy shields vulnerable patients from severe COVID-19
- Could a shorter steroid course be just as good for HIV-Related pneumonia?
- Could a lower dose of antibiotics be safer and just as effective for this lung infection?
- New drug could shield transplant patients from deadly fungal infections